• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Role of vertical transmission of HTLV-I on the risk for T cell malignancy

Research Project

Project/Area Number 12470052
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Experimental pathology
Research InstitutionTokyo Medical and Dental University

Principal Investigator

KANNAGI Mari  Tokyo Medical and Dental University Graduate School, Immunotherpeutics, Professor, その他の独立研究科, 教授 (80202034)

Project Period (FY) 2000 – 2001
Project Status Completed (Fiscal Year 2001)
Budget Amount *help
¥10,800,000 (Direct Cost: ¥10,800,000)
Fiscal Year 2001: ¥4,700,000 (Direct Cost: ¥4,700,000)
Fiscal Year 2000: ¥6,100,000 (Direct Cost: ¥6,100,000)
KeywordsImmune torelance / Vertical infection / Virus / Infection immunity / Tumor immunity / HTLV-I / HTLV-1
Research Abstract

The level of host immune responses against HTLV-I varies among HTLV-I-infected individuals. In the present study, we examined the effect of the routes of HTLV-I-transmission on the host anti-HTLV-I immune responses. When immune competent adult rats were inoculated with HTLV-I-infected cells, the orally infected rats were persistently infected with HTLV-I without humoral and cellular immune responses against HTLV-I, whereas all intravenously or intraperitoneally inoculated rats showed significant levels of immune responses. Similar defects of humoral and cellular immunity specific for HTLV-I were observed in offsprings from HTLV-I infected rats. These observations indicated that host anti-HTLV-I immunity can be affected by the conditions of the primary infection, especially in. This study provides an experimental evidence that vertical transmission can be a reason for low cell-mediated immunity against HTLV-I, which is considered to be one of the risk factors for adult T cell leukemia.

Report

(3 results)
  • 2001 Annual Research Report   Final Research Report Summary
  • 2000 Annual Research Report
  • Research Products

    (21 results)

All Other

All Publications (21 results)

  • [Publications] S.Hanabuchi, T.Ohashi, Y.Koya, H.Kato, A.Hasegawa, F.Takemura, T.Masuda, M.Kannagi: "Regression of Human T-cell leukemia virus type I(HTLV-I)-lymphomas in a rat model : Peptide-induced T-cell immunity"J. Natl. Cancer Inst.. 93. 1775-1783 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] M.Kannagi, S.Hanabuchi, T.Ohashi, A.Hasegawa, T.Masuda: "Host defense Mechanisms against HTLV-I-induced T cell lymphomas in a rat model"AIDS Res. Hum. Retroviruses. 17(Suppl.1). S14 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] T.Ohashi, S.Hanabuchi, H.Kato, H.Tateno, F.Takemura, T.Tsukahara, Y.Koya, A.Hasegawa, T.Masuda, M.Kannagi: "Prevention of adult T cell leukemia-like lymphoproliferative disease in rats by adoptively transferred T cells from a donor immunized with human T cell leukemia virus type I Tax-coding DNA vaccne"J. Virol.. 74. 9610-9616 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] M.Kannagi, T.Ohashi, S.Hanabuchi, H.Kato, Y.Koya, A.Hasegawa, T.Masuda, T.Yoshiki: "Immunological aspects of rat modeis or HTLV-type I-infected T lymphoproliferative disease"AIDS Res. Hum. Retroviruses. 16. 1737-1740 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] S.Hanabuchi, T.Ohashi, Y.Koya, H.Kato, F.Takemura, K.Hirokawa, T.Yoshiki, H.Yagita, K.Okumura, M.Kannagi: "Development of human T cell leukemia virus type I(HILV-I)-transformed tumor in rats following suppression of T cell immunity by CD8O and CD86 blockade"J. Virol.. 74. 428-435 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] 神奈木真理: "ヒトT細胞白血病ウイルス感染に対する抗腫瘍ワクチン"がん治療のあゆみ. 20. 21-28 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] 大橋 貴, 神奈木真理: "「ヒトレトロウイルス研究の最前線」、ATLの動物モデルと宿主免疫"シュプリンガー・フェアクラーク社(山本直樹編)(印刷中). (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] S. Hanabuchi, T. Ohashi, Y. Koya, H. Kato, A Hasegawa, F. Takemura, T. Masuda, M Kannagi: "Regression of Human T-ceH leukemia virus type I (HTLV-I)-lymphomas in a rat model : Peptide induced T-cel l immunity"J. Natl. Cancer Inst.. 93. 1775-1783 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] M. Kannagi, S. Hanabuchi, T. Ohashi, A. Hasegawa, T. Masuda: "Host defense mechanisms against HTLV-I-induced T cell lymphomas in a rat model"AIDS Research and Human Retroviruses. 17(Suppl. 1). S14 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] M. Kannagi, T. Ohashi, S. Hanabuchi, H. Kato, Y. Koya, A. Hasegawa, T. Masuda, and T. Yoshiki: "Immunological aspects of rat models of HTLV-type 1-infected T lympho-proliferative disease"AIDS Res. Hum. Retroviruses. 16. 1737-1740 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] T. Ohashi, S. Hanabuchi, H. Kato, H. Tateno, F. Takemura, T. Tsukahara, Y. Koya, A. Hasegawa, T. Masuda, and M. Kannagi: "Prevention of adult T cell leukemia-like lymphoproliferative desease in rats by adoptively transferred T cells from a donor immunized with human T cell leukemia virus type I Tax-coding DNA vaccine"J. Virol. 74. 9610-9616 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] S. Hanabuchi, T. Ohashi, Y. Koya, H. Kato, F. Takemura, K. Hirokawa, T. Yoshiki, H. Yagita, K. Okumura, and M. Kannagi: "Development of human T cell leukemia virus type I(HTLV-I)-transformed tumor in rats following suppression of T cell immunity by CD80 and CD86 blockade"J. Virol.. 74. 428-435 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] S.Hanabuchi, T.Ohashi, Y.Koya. H.Kato, A.Hasegawa, F.Takemura, T.Masuda, M.Kannagi: "Regression of Human T-cell leukemia virus type I (HTLV-1)-lymphomas in a rat model : Peptide-induced T-cell immunity"J. Nati. Cancer Inst.. 93. 1775-1783 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] M.Kannagi, S.Hanabuch, T.Ohashi, A.Haseqawa, T.Masuda: "Host defense Mechanisms against HTLV-1-induced T cell lymphomas in a rat model"AIDS Res. Hum. Retroviruses. 17(suppl.1). S14 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] 神奈木真理: "ヒトT細胞白血病ウイルス感染に対する抗腫瘍ワクチン"がん治療のあゆみ. 20. 21-28 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] 大橋 貴, 神奈木真理: "「ヒトレトロウイルス研究の最前線」、ATLの動物モデルと宿主免疫"シュプリンガー・フェアクラーク社(山本直樹編)(印刷中). (2002)

    • Related Report
      2001 Annual Research Report
  • [Publications] T.Ohashi,S.Hanabuchi,H.Kato,H.Tateno,H.Takemura,T.Tsukahara,Y.Kova,A.Hasegawa,T.Masuda,and M.Kannagi.: "Prevention of adult T cell leukemia-like Iymphoproliferative disease in rats by adoptively transferred T cells from a donor immunized with human T cell leukemia virus type I Tax-coding DNA vaccine."J.Virol.. 74. 9610-9616 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] M.Kannagi,T.Ohashi,S.Hanabuchi,H.Kato,Y.Koya,A.Hasegawa,T.Masuda,and T.Yoshiki.: "Immunological aspects of rat models of HTLV-type I-infected T lymphoproliferative disease."AIDS Res.Hum.Retroviruses. 16. 1737-1740 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] S.Hanabuchi,T.Ohashi,Y.Kova,H.Kato,F.Takemura,K.Hirokawa,T.Yoshiki,H.Yagita,K.Okumura,and M.Kannagi.: "Development of human T cell leukemia virus type I (HTLV-I)-transformed tumor in rats following suppression of T cell immunity by CD80 and CD86 blockade. "J.Virol.. 74. 428-435 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] 神奈木真理: "HTLV-Iリンパ腫瘍と免疫"現代医療. 32(12). 2755-2760 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] 神奈木真理: "ウイルス感染より見た免疫応答、HTLV-I."臨床と微生物. 27. 053-058 (2000)

    • Related Report
      2000 Annual Research Report

URL: 

Published: 2000-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi